Maravai LifeSciences Corp - MRVI Net earnings per share for the last four quarters

Public company logo of Maravai LifeSciences Corp (MRVI)

Maravai LifeSciences (MRVI) supplies advanced reagents for mRNA therapies, leveraging a broad customer base ranging from startups to tech giants. The rolling year net income per share trend illustrates the moderate cyclicality of demand for R&D services, where 46.50 shapes the current metric. Ultimate margin resilience is based on strong technological potential, despite the dependence on laboratory capital expenditures.

MRVI Maravai LifeSciences Holdings, Inc.: Earnings per share for the last twelve months in the range 02/11/2024 - 11/18/2026

MRVI (Maravai LifeSciences): analytical breakdowns and indicator data

Fundamental company valuation:MRVI - Maravai LifeSciences Corp
Mass-produced product of Maravai

The stable moat of Maravai LifeSciences (MRVI), secured by mRNA modification patents and high customer stickiness, directly drives earnings per share dynamics. By analyzing this chart of year-over-year EPS changes on a rolling basis, an investor can assess the annual net income growth rate, allowing for the differentiation of sustainable business development from short-term fluctuations and the determination of the asset's investment grade.

Direct competitors

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)